Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet the urgent need for treatments that have the potential to restore liver function and prevent the progression to liver failure across multiple liver diseases that are untreatable or poorly treated today.

Education

Biotechnology

Ambys Medicines

John Choi

John McKeon

Samira Shaikhly

Priyadarshini Podishetti

Stanley Hollenbach

Asit Parikh

Abeba Demelash Ph.D.

Gabriel Peixoto

Gaetano ‘Nino’ Faleo

Padma Priya Togarrati, Ph.D., RAPS

Tejon McRae

Scientific and Clinical Team

Leadership Team

Directors and People Operations

��

Teams at Ambys Medicines

Scientific and Clinical Team

Leadership Team

Directors and People Operations

��������

Teams at Ambys Medicines

Scientific and Clinical Team

Leadership Team

Directors and People Operations

��